SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
1-Year Return
40.04%
This Quarter Return
+9.04%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$185M
AUM Growth
+$7.74M
(+4.4%)
Cap. Flow
-$652K
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
70.79%
Holding
31
New
10
Increased
8
Reduced
8
Closed
3
Top Buys
| 1 |
Enanta Pharmaceuticals
ENTA
|
$11.1M |
| 2 |
Vanda Pharmaceuticals
VNDA
|
$10.5M |
| 3 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$7.56M |
| 4 |
CUTR
Cutera, Inc.
CUTR
|
$4.53M |
| 5 |
NEOS
Neos Therapeutics, Inc
NEOS
|
$4.13M |
Top Sells
| 1 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
$15.9M |
| 2 |
ALR
Alere Inc
ALR
|
$8.78M |
| 3 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$7.34M |
| 4 |
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
|
$5.25M |
| 5 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$3.33M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CareDx
CDNA
$697M
| $212K | 0.11% |
+190,909
| New | +$212K |
|
|
FOMX
27
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $13K | 0.01% |
+2,878
| New | +$13K |
|
28
Emergent Biosolutions
EBS
$407M
| – | – |
-54,505
| Closed | -$1.58M |
|
|
VXRT
29
DELISTED
Vaxart
VXRT
| – | – |
-28,584
| Closed | -$205K |
|
30
Xoma
XOMA
$428M
| – | – |
-87,960
| Closed | -$625K |
|